BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Liver
,
Autoimmunity
,
Aspirin
,
rs4950928
,
MDM2
,
nitric oxide metabolic process
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
human HCC cells
Summary
General Info
Curated Studies
Most Correlated Studies
Hepatocellular carcinoma (HCC) - gene expression signatures of NANOG+ and NANOG- HCC cells
HCC Hep G2 cells with nimesulide, nefazodone, trovafloxacin, aspirin, buspirone or levofloxacin
HCC Hep G2 and CML K562 cells with KHSRP siRNA knockdown
Hepatocellular carcinoma HCC-LM3 cells with PLAGL2 shRNA knockdown
Hepatocellular carcinoma (HCC) models under different culture conditions
Explore Curated Studies Results
Literature
Most Relevant Literature
Differential expression of the anterior gradient protein-2 is a conserved feature during morphogenes…
Association of gankyrin protein expression with early clinical stages and insulin-like growth factor…
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carc…
Cultured Cells from the Human Oocyte Cumulus Niche Are Efficient Feeders to Propagate Pluripotent St…
Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C viru…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Neoadjuvant Anti-PD1 in HCC
Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced…
TheraSphere With and Without Durvalumab and Tremelimumab for HCC
Optimization for Regorafenib in HCC
Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ